| Drug Name: | Orlistat (96829-58-2) |
|---|---|
| PubChem ID: | 3034010 |
| SMILES: | CCCCCCCCCCC[C@@H](C[C@H]1[C@@H](C(=O)O1)CCCCCC)OC(=O)[C@H](CC(C)C)NC=O |
| InchiKey: | AHLBNYSZXLDEJQ-FWEHEUNISA-N |
| Therapeutic Category: | Anti-Obesity Agents, Central Nervous System Agents, Enzyme Inhibitors |
| Molecular Weight (dalton) | : | 495.745 |
| LogP | : | 6.8819 |
| Ring Count | : | 0 |
| Hydrogen Bond Acceptor Count | : | 5 |
| Hydrogen Bond Donor Count | : | 1 |
| Total Polar Surface Area | : | 81.7 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|---|---|---|---|
| Enalapril (75847-73-3) | Intracranial Haemorrhage | Antagonistic | Not Understood | Interaction between orlistat and antihypertensive drugs |
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category